Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids
US8883426B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 20, 2008 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Apr 19, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of therapeutically active lipids for organ/tissue-specific enrichment for the treatment of inflammatory, ischemic or degenerative disorders and/or for stimulating a regeneration is arranged and developed such that the lipids are bound on application to carrier molecules for which cell-specific uptake systems in the cells of the organs and/or tissue exist. In addition, a method of producing organ/tissue-specific therapeutically active lipids for treatment of inflammatory, ischemic or degenerative disorders and/or stimulation of a regeneration, in particular for treating inflammatory liver disorders, is claimed, which is arranged and developed such that lysophosphatidylethanolamine (LysoPE) is coupled to the carboxyl group of ursodeoxycholate (UrsoDOCA) converted to an ester to give a LysoPE-DOCA compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.